Publication Name	World Journal of Virology
Manuscript ID	100160
Country	Bangladesh

Received	2024-08-08 10:58
Peer-Review Started	2024-08-08 10:58
To Make the First Decision
Return for Revision	2024-09-17 03:49
Revised	2024-09-24 04:42
Second Decision	2024-10-14 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-15 08:07
Articles in Press	2024-10-15 08:07
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-22 12:10
Publish the Manuscript Online	2024-11-28 03:06

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Virology
Manuscript Type	Letter to the Editor
Article Title	Rhabdomyolysis-related acute kidney injury in COVID-19: A critical concern
Manuscript Source	Invited Manuscript
All Author List	Md Safiullah Sarker
Funding Agency and Grant Number
Corresponding Author	Md Safiullah Sarker, PhD, Virology Laboratory, Infectious Diseases Division, 68 Shaheed Tajuddin Ahmed Sarani, Dhaka 1212, Bangladesh. ssarker@icddrb.org
Key Words	Rhabdomyolysis; Acute kidney injury; COVID-19; SARS-CoV-2; Creatine kinase; Inflammation; Prognosis; Mortality
Core Tip	Rhabdomyolysis is a significant complication in COVID-19 patients, leading to severe acute kidney injury (AKI) with high mortality rates. This editorial highlight a study that found higher inflammatory markers and worse outcomes in patients with rhabdomyolysis-related AKI compared to other causes of AKI. Early detection and appropriate management are crucial to mitigate the adverse effects of this condition in the context of COVID-19.
Publish Date	2024-11-28 03:06
Citation	<p>Sarker MS. Rhabdomyolysis-related acute kidney injury in COVID-19: A critical concern. <i>World J Virol</i> 2025; 14(1): 100160</p>
URL	https://www.wjgnet.com/2220-3249/full/v14/i1/100160.htm
DOI	https://dx.doi.org/10.5501/wjv.v14.i1.100160

Full Article (PDF)	WJV-14-100160-with-cover.pdf
Manuscript File	100160_Auto_Edited_025905.docx
Answering Reviewers	100160-answering-reviewers.pdf
Audio Core Tip	100160-audio.mp3
Conflict-of-Interest Disclosure Form	100160-conflict-of-interest-statement.pdf
Copyright License Agreement	100160-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100160-non-native-speakers.pdf
Peer-review Report	100160-peer-reviews.pdf
Scientific Misconduct Check	100160-scientific-misconduct-check.png
Scientific Editor Work List	100160-scientific-editor-work-list.pdf
CrossCheck Report	100160-crosscheck-report.pdf